Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis
Authors:
- Amir Masoud AfsahiAAAmir Masoud Afsahi
- Alexander M. NorbashANAlexander M. Norbash
- Shahla F. SyedSSShahla F. Syed
- Maya SedaghatMSMaya Sedaghat
- Ghazaleh AfsahiGAGhazaleh Afsahi
- Ramin ShahidiRSRamin Shahidi
- Zohreh TajabadiZTZohreh Tajabadi
- Mahsa Bagherzadeh-FardMBMahsa Bagherzadeh-Fard
- Shaghayegh KaramiSKShaghayegh Karami
- Pourya YarahmadiPYPourya Yarahmadi
- Shabnam ShirdelSSShabnam Shirdel
- Ali AsgarzadehAAAli Asgarzadeh
- 3 August 2023
- journal article
- review article
- Published by Springer Nature in Journal of Neurology
- Vol. 270 (11) , 5131-5154
Abstract
Background Coronavirus disease 2019 (COVID-19) has been associated with nervous system involvement, with more than one-third of COVID-19 patients experiencing neurological manifestations. Utilizing a systematic review, this study aims to summarize brain MRI findings in COVID-19 patients presenting with neurological symptoms. Methods Systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) checklist. The electronic databases of PubMed/MEDLINE, Embase, Scopus, and Web of Science were systematically searched for literature addressing brain MRI findings in COVID-19 patients with neurological symptoms. Results 25 publications containing a total number of 3118 COVID-19 patients with neurological symptoms who underwent MRI were included. The most common MRI findings and the respective pooled incidences in decreasing order were acute/subacute infarct (22%), olfactory bulb abnormalities (22%), white matter abnormalities (20%), cerebral microbleeds (17%), grey matter abnormalities (12%), leptomeningeal enhancement (10%), ADEM (Acute Disseminated Encephalomyelitis) or ADEM-like lesions (10%), non-traumatic ICH (10%), cranial neuropathy (8%), cortical gray matter signal changes compatible with encephalitis (8%), basal ganglia abnormalities (5%), PRES (Posterior Reversible Encephalopathy Syndrome) (3%), hypoxic-ischemic lesions (4%), venous thrombosis (2%), and cytotoxic lesions of the corpus callosum (2%). Conclusion The present study revealed that a considerable proportion of patients with COVID-19 might harbor neurological abnormalities detectable by MRI. Among various findings, the most common MRI alterations are acute/subacute infarction, olfactory bulb abnormalities, white matter abnormalities, and cerebral microbleeds.Keywords
This publication has 65 references indexed in Scilit:
- Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 InfectionRadiology, 2020
- Nervous system involvement after infection with COVID-19 and other coronavirusesBrain, Behavior, and Immunity, 2020
- Extrapulmonary and atypical clinical presentations of COVID‐19Journal of Medical Virology, 2020
- Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)Journal of Medical Virology, 2020
- Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathologyActa Neuropathologica, 2020
- The COVID‐19 epidemicTropical Medicine & International Health, 2020
- Multiscale Imaging Approach for Studying the Central Nervous System: Methodology and PerspectiveFrontiers in Neuroscience, 2020
- Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and ManifestationsRadioGraphics, 2017
- Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosisNeurology, 2015
- Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validityJournal of Clinical Epidemiology, 2013